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About 30-40% of random-bred Hartley (I) and all  strain  2 (2) guinea pigs  recog- 
nize  poly-L-lysine  (PLL)  I  and hapten-PLL conjugates  as  antigens.  These "responder" 
animals develop delayed hypersensitivity  to the conjugated polymer and produce 
specific  antihapten  antibodies  when  immunized  with  hapten-PLL  conjugates.  The 
ability to respond to these antigens was shown to be controlled by a  dominant auto- 
somal  gene  (2,  3).  Hapten-PLL  conjugates  which  are  complete  antigens  only  for 
responder animals can behave as haptens in genetic nonresponder guinea pigs. Thus, 
insoluble  electrostatic  complexes formed by the  reaction  of positively charged  2,4- 
dinitrophenyl-PLL (DNP-PLL) with negatively charged foreign albumins,  acting as 
conveyor or Schlepper molecules, induce the formation of high serum levels of anti- 
DNP antibodies in nonresponder guinea pigs (4). These animals, however, in contrast 
with responder guinea pigs, do not show delayed hypersensitivity reactions to DNP- 
PLL, which is not surprising, since it is well known that unconjugated haptens cannot 
elicit delayed hypersensitivity reaction (5).  In these systems, the recognition of anti- 
genicity and the capacity to show delayed hypersensitivity reactions therefore involve 
some identical immunological recognition mechanism in  which the specificity of the 
carrier molecule plays an important part.  This relationship  is further  illustrated  by 
the observations of Schlossman on the ez DNP-oligo-L-lysines that the same minimum 
number of 7-8 lysine residues  is essential both for immunization of responder guinea 
pigs and for the elicitafion of delayed hypersensitivity reactions in these animals (6, 7). 
An  understanding  of  the  immune  response  to  hapten-protein  and  hapten-poly- 
peptide conjugates must depend upon a better knowledge of the hapten-carrier rela- 
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tionship. Since the definition of hapten and of complete antigens by Landsteiner (8) 
and  his  demonstration  that  the  immune  response  could  be  directed  towards well- 
defined chemical structures, provided they were covalently bound  or complexed by 
ionic forces to protein antigens, great advances have been made with the help of these 
immunological systems. But very little work has been directed to the understanding 
of the hapten-carrier relationship with regard to the mechanism by which an immuno- 
genic carrier molecule renders a  hapten capable of inducing the formation of specific 
antibodies. The immune response to DNP-PLL complexed with foreign albumins in 
guinea pigs genetically unable to recognize DNP-PLL  as antigen constitutes a  par- 
ticularly suitable system in which  to  study  the processes by which  the  carrier con- 
fers antigenicity to a  hapten  (4).  Two  mechanisms  can be proposed to explain this 
phenomenon: 
(a) The carrier molecule allows antibody to the hapten to be synthesized by forming 
with the hapten a new and complete antigenic determinant. This interpretation postu- 
lates that  the  specificity of the antihapten antibodies involve both the hapten and 
adjacent areas of the carrier molecule. According to this view, the energy that will 
allow binding of a  sufficient amount of antigen to induce the immune response is only 
provided by adding the contribution of the carrier to the immunological specificity of 
the  hapten.  In  support  of  this  interpretation,  there  has  been  ample  evidence  for 
carrier specificity in hapten-protein and hapten-polypeptide systems for the reactions 
of actively sensitized cells with antigen such as delayed hypersensitivity (9,  10,  11) 
and anamnestic reactions (12). In the hapten-PLL system, an unequivocal example 
of antibody with carrier specificity has been reported in the case of anti-DNP-PLL 
antibodies produced by genetic responder guinea pigs. These antibodies show partial 
specificity for the PLL carrier molecule (13). However, the specificity of the DNP-PLL 
antibodies produced by genetic nonresponder guinea pigs immunized with DNP-PLL 
complexed with  ovalbumin is not consistent with  the above hypothesis: these anti- 
bodies were  shown  by fluorescent-quenching technique  to  have  identical specificity 
towards PLL as the antibodies produced by responder guinea pigs immunized with 
DNP-PLL  alone. No contribution of the foreign albumin conveyor molecule to the 
specificity of these antibodies could be detected (4). 
(b)  According to an alternative mechanism,  the conveyor foreign molecule is first 
recognized as antigenic by an unknown process, and then it allows an immune response 
to be induced to all specific determinants to which it is bound.  One of the questions 
that may be asked in exploring this possibility is whether the antibody produced to 
DNP-PLL  and  to  the  antigenic  determinants  of  the  conveyor  albumin  by  non- 
responder guinea pigs are synthesized in the same or in different plasma ceils. This 
question is very appropriate since in nonresponder guinea pigs the presence of the 
conveyor molecule is an absolute requirement for the  production of anti-DNP-PLL 
antibodies. For two reasons, this immunological system is also ideally suited to answer 
the general problem posed in the companion paper  (14),  whether individual plasma 
cells synthesize antibodies of different specificities; because in this  case the animals 
are presented with an antigenic complex in which the response to the two types of 
determinants is intimately linked (4)  and because after immunization of genetic non- 
responder  guinea  pigs  with  DNP-PLL  albumin  complexes  only  anti-DNP-PLL 
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are detected  (13).  Thus, in contrast with  the antibodies  elicited by hapten-protein 
conjugates, link antibody and anti-hapten antibody with specificity for the conveyor 
molecule have not been demonstrated in this system. As in the companion paper (14), 
the classical Coon's sandwich technique (15) using sequential double immunofluores- 
cent labeling, and a  combination of this technique with radioautography  (16),  were 
used to identify the immunological specificity of the antibodies produced by individual 
ceils from  nonresponder guinea pigs immunized with  complexes of DNP-PLL  with 
ovalbumin or with bovine serum albumin. 
Material and Methods 
Polypeptides  and  Protein.--Poly-L-lysine  hydrobromide  (PLL)  with  average  molecular 
weight of 90,000 was obtained from Pilot Chemical Co.,  Watertown, Mass.  Bovine serum 
albumin (BSA) and bovine gamma globulin (BGG) were obtained from Armour Pharmaceu- 
tical Co.,  Chicago,  Ill. Five times recrystallized hen ovalbumin (OVA) was obtained from 
Pentex, Inc., Kankakee, Ill. Guinea pig albumin (GPA) was prepared by starch block electro- 
phoresis separation of guinea pig serum (17). 
Other Reagents.--Freund's  complete adjuvant was obtained from Difco Laboratories, Inc., 
Detroit,  Mich.  1-lluoro-2,4-dinitrobenzene (DNFB)  was  obtained from  Eastman Organic 
Chemicals, Rochester, N. Y. 12~I, carrier-free,  was obtained from the New England Nuclear 
Corp.,  Boston,  Mass. 
Fluorescein isothiocyanate (FITC) and tetramethylrhodamine isothiocyanate (RITC) were 
purchased from the Baltimore Biological Laboratories, Baltimore, Md. 
Preparation  of Conjugates.--DNP-PLL  was  prepared  by reacting PLL  with  DNFB  in 
dinxane under alkaline conditions as previously described  (9). 
Polypeptide and protein concentrations were determined by micro-Kjeldahl nitrogen meas- 
urements. The degree  of DNP substitution was calculated from the absorbancy at 360 m/z 
on the basis of the molar extinction coefficient of free ~-DNP-r.-lysine (e 360/zm -- 17,400) (18). 
A single DNP~0-PLL430 conjugate was used for this study. The subscripts refer respectively 
to the average number of groups of hapten and the average number of lysine residues in the 
molecule. 
Preparation of DNP-P£L Albumin Complexes.--Equal  amounts by weight of OVA or BSA 
(at concentration of 5 mg/ml in 0.075 ~  NaC1) were added to a solution of 5 mg/ml of DNP- 
PLL in 0.075 ,x NaC1. 0.I N NaOH was added dropwise  until a precipitate formed. 
Immuuization.--Male and female Hartley guinea pigs weighing 300 to 400 g were purchased 
from Carom Research Laboratories, Wayne, N. J. The animals were immunized in the four 
footpads with 0.2 mg of DNP-PLL. albumin complex in 0.4 ml of emulsion containing equal 
volumes of the antigen and of complete Freund's adjuvant. Booster  injections of 50/zg of 
DNP-PLL albumin complex and 10/zg of DN'P-PLL were given intradermally at 7-8 days. 
Immune  Response to  DNP-PLL  Albumin  Complexes.--The  intensity of  delayed  hyper- 
sensitivity reactions to DNP-PLL was evaluated 24 hr after intradermal injection of 10 #g of 
DNP-PLL in 0.1 ml of 0.15 ~.NaC1. The presence of serum antibodies against DN-P-PLL, 
BSA, or OVA was revealed by double diffusion analysis in agar gel using immunoplates from 
Hyland Laboratories, Los Angeles,  Calif.,  and DNP4t-GPA, BSA, or OVA at the concentra- 
tion of 0.25 mg/ml. 
Detection of the Antibodies Produced by Individual  Ce//s.--After immunization of random- 
bred guinea pigs with DNP-PLL albumin complex,  the genetic nonresponder animals were 
identified by their lack of delayed hysersensitivity to DN'P-PLL (4). These animals were killed 
from  13 to 23 days after immunization and cell smears were prepared from the peripheral 
lymph nodes draining the sites of injection, as described in the preceding paper (14). The anti- 530  CELLULAR  LOCALIZATION  OF ANTIBODIES 
body-producing cells were identified by a combination of immunofluoreseent techniques and 
radioautography.  Since the  procedures and reagents used in these experiments have  been 
described in detail in the companion paper (14), they will only be briefly discussed. The only 
new reagents used in the present study were ovalbumin 0.2 mg/ml as a middle layer antigen 
and rabbit anti-OVA antibodies labeled with fluorescein to identify anti-OVA antibody-pro- 
ducing ceils. The rabbit anti-OVA antibodies were prepared by immunizhlg rabbits in the 
footpads with 2 nag of ovalbnmin in complete adjuvant. The animals  were bled 2-3 wk after 
immunization, the gamma globulin fraction was conjugated with fluorescein. In the case of 
guinea pigs immunized with DNP-PLL.BSA, the basic approach was first to expose fixed cell 
smears to a mixture of BSA and DNPla-BGG. These middle layer antigens fixed to cells making 
antibody directed against BSA and the DN-P determinant respectively. The smears were then 
washed and treated with a mixture of rabbit anti-BSA antibodies labeled with fluorescein  and 
of anti-DNP purified rabbit antibodies labded with rhodamine. Cells producing anti-BSA 
antibodies would be expected to stain green and cells producing anti-DNP antibodies would 
be expected to stain orange. Cells making both types of antibody would be stained yellow. 
Two additional techniques were also employed as described in the companion paper (14): 
(a) Sequential double fluorescent staining. The slide was treated with one set of reagents, BSA 
middle layer  followed by fluorescein-labeled anti-BSA antibody. Specific fields containing 
green cells were identified by Vernier readings and photographed. The same slides were then 
treated with the second set of reagents, DN'Ple-BGG as the middle layer antigen followed by 
rhodamine-labeled anti-DNP antibody.  The appearance of the newly stained cells or of a 
change of color, if any, of the previously green-stained cells was recorded. This type of experi- 
ment was also carried out using OVA and fluorescein-labeled  rabbit anti-OVA antibodies in 
those anlma]s immunized with DNP-PLL.OVA.  (b) Combined double fluorescent and radio- 
autographic technique. Here, a smear was treated with the double antigen middle layer mix- 
ture, DNP16-BGG  and BSA labeled with 125I (BSA-125I).  The smear was then treated with a 
mixture of purified rabbit anti-DNP antibody labeled with rhodamine and rabbit anti-BSA 
antibody labeled with fluorescein. Fields were identified and photographed which contained 
green and orange cells. The slides were prepared for mdioautographic examln~tion by dipping 
in photographic emulsion. After a suitable time interval, the radioautographs were developed 
and the smears were stained with Giemsa. The same fields were again identified. It was noted 
which of the previously green and orange ceils had grains localized over them. Only the anti- 
BSA-producing cells would be expected to have attracted  BSA-126I and thus to have grains 
over them. If any orange cells showed grains over them, this would indicate that they were 
making small amounts of BSA antibodies in addition to anti-DN'P antibodies. 
RESULTS 
When the lymph node cells were reacted with the  two sets  of reagents to 
detect anti-DNP-producing cells and anti-BSA- or anti-OVA-producing cells, 
the stained plasma cells were stained either green (anti-BSA or anti-OVA) or 
orange  (anti-DNP). No  yellow  plasma  cells  were  seen.  The  only cellular 
material which stained yellow was some occasional eosinophile granules. 
The results of sequential staining experiments are presented in Table I. 
The cells of five individual animals were studied. The sequential staining was 
performed in both directions; in some experiments the antiaibumin-producing 
cells were detected first, followed by the identification of the cells producing 
anti-DNP antibodies; in other experiments the order was reversed. A  total of GREEN~  VASSALLI~ AND  BENACERRAF  531 
TABLE  I 
Identlf~agon  by Sequential Fluorescent Staining  of Ang-BSA- or Anti-OVA-Producing 
Cells and of Anti-DNP-Producing Calls in Genetic Nonresponder Guinea Pigs 
Immunized ugth DNP-PLL. BSA or DNP-PLL.O VA 
Experiment No. 
18-82" 
19-45" 
19-44:~ 
19-58§ 
20-1411 
Immunizing  antigen 
DNP-PLL. OVA 
DNP-PLL. OVA 
DNP-PLL- 0VA 
DNP-PLL. BSA 
DNP-PLL- BSA 
No.  of days 
after 
immunization 
16 
15 
16 
23 
17 
No. of anti- 
OVA or 
auti-BSA- 
producing cells 
80 
108 
16 
7 
11 
No. of anti- 
DNP=pro~ 
ducing 
cells  seen 
19 
65 
20 
15 
56 
Total .......  222  175  0 
No. double 
producers 
* The anti-OVA cells were identified first by fluorescein-labeled antibody. 
:~ The anti-DNP cells were identified first by rhodamine-labeled antibody, then the same 
fields were reexamined after staining for OVA-producing cells with fluorescein-labeled anti- 
body. 
§ The anti-BSA cells were identified first by fluorescein-labeled antibody. The same fields 
were reexamined after staining for DNP-producing cells with rhodamine-labeled antibody. 
[1 The  anti-DNP-producing  cells were  identified  first with rhodamine-labeled antibody. 
The same fields were then reexamined after staining for BSA-producing cells using fluorescein- 
labeled antibody. 
TABLE  II 
Identification by Combined Fluorescent and RadioautograpMc Technique of Anti-BSA- 
Producing Cells and Ang-DNP-Producing Cells in Genetic,  Nonresponder 
Guinea Pigs Immunized with DNP-PLL.BSA 
Exp~r~.~nen  t 
19-58 
19-53 
21-03 
total  .... 
Immunizing antigen 
DNP-PLL.  BSA 
DNP-PLL.  BSA 
DNP-PLL.BSA 
No. of days 
after im- 
munization 
23 
23 
13 
No. anti-BSA 
cells seen by 
fluorescent 
staining and 
radloautog- 
raphy* 
21 
16 
22 
59 
No. of anti- 
DNP cells 
seen b~ 
rhodamme 
fluorescence 
17 
13 
4O 
70 
No. of anti- 
DNP cells 
exhibiting 
BSA 
specificity by 
radioautog- 
raphy~ 
o/17 
o/13 
o/4o 
* The same cells were always identified by both techniques. 
These are the same previously identified anti-DNP cells. 532  CELLULAR  LOCALIZATION  OF  ANTIBODIES 
397 antibody-producing cells were identified. These cells produced either anti- 
DNP antibody (orange cells) or antibodies against the conveyor albumin (green 
cells). No cell (yellow cells)  could be found which produced antibodies of both 
specificities. Figures 1 a  and 1 b illustrate the sequential staining experiments. 
The results of the second type of experiments are presented in Table II. Here, 
the anti-BSA-producing cells were identified by immunofluorescence and later 
by the radioautographic localization of 125I-labeled BSA over the cell. In these 
very same  fields,  anti-DNP-producing  cells  were  identified by their  orange 
color. If the anfi-DNP-producing cells  were also producing small amounts of 
anti-BSA antibody, then some grains should have appeared over these cells as 
well.  As  indicated in  Table II,  a  total of 59  anti-BSA-producing cells  were 
localized by fluorescein fluorescence and radioautogrxphy. (It should be noted 
that there were always grains over the cells previously stained green.) In these 
same fields, a total of 70 orange anti-DNP-producing cells were seen; in no case 
did any grains appear over these anti-DNP-producing cells at a concentration 
higher than the background. Figures 2 a and 2 b are examples of the experiments 
combining immunofluorescent and radioautographic technique. Therefore, from 
the results of these two objective experiments no cells were seen which produced 
antibodies against DNP-PLL and the conveyor albumin molecule ovalbumin or 
BSA. 
Several additional observations were made in the course of these experiments 
which deserve mention. First, the same two separate color classes  of antibody- 
producing cells were seen in a few genetic responder animals that were studied. 
It was noted that, in the lymph nodes of genetic responder guinea pigs immu- 
nized with DNP-PLL. BSA, anti-DNP antibody-producing ceils were seen very 
early, at 7-8 days, at which time few if any anti-BSA-producing cells could be 
seen.  These latter  cells appeared in  large numbers  at  about  10-12  days.  In 
genetic nonresponder animals immunized with DNP-PLL-BSA, neither anti- 
DNP-producing cells  or anti-BSA-producing cells were seen at 7-8 days, but 
both types of cells were seen in large numbers at 10-12 days. The time sequence 
of the appearance of serum antibody to the dinitrophenyl hapten and to the 
conveyor molecules paralleled the observations made on the appearance of the 
lymph node cells producing these two respective antibodies. 
DISCUSSION 
Genetic nonresponder guinea pigs  unable to show  an  immune response to 
DNP-PLL can nevertheless recognize this molecule as  a  hapten when immu- 
nized with DNP-PLL complexed with a foreign albumin (4). These animals then 
produce two types of antibodies, antibodies against the DNP-PLL hapten and 
antibodies against antigenic determinants of the conveyor molecule. These two 
types of antibodies have completely different specificities; the anti-DNP-PLL 
antibodies could not be shown to have carrier specificity for the conveyor albu- GREEN~  VASSALLI,  AND  BENACERRAF  533 
rain (4). In spite of their different specificities,  the synthesis of these two anti- 
bodies is clearly linked by some initial event involving the recognition of the 
immunogenicity of the conveyor molecule, since  these  genetic nonresponder 
animals are incapable of forming antibodies to DNP-PLL when the conjugate 
is injected alone and do not give a delayed response to DNP-PLL (4).  This is 
further illustrated by the observation that after immunization of nouresponder 
guinea pigs  with DNP-PLL.BSA,  large  numbers  of plasma  cells  containing 
anti-DNP-PLL antibodies or anti-BSA antibodies appeared at the same time, 
at about 12 days, in the lymph nodes draining the injection site, while in re- 
sponder guinea pigs, plasma cells  containing anti-DNP-PLL  antibodies were 
seen 4  days before the appearance of plasma cells  containing anti-BSA anti- 
bodies. In spite of the fact that some common initial event controls the synthe- 
sis  of DNP-PLL and of anti-BSA or anti-OVA  antibodies in genetic nonre- 
sponder  animals  immunized with  DNP-PLL-BSA  or  DNP-PLL.OVA,  the 
results of these experiments demonstrate that the antibodies against DNP-PLL 
and the antibodies against the specific determinants of the conveyor albumins 
are synthesized in different plasma cells. 
If some initial recognition of immunogenicity of a carrier molecule, as earlier 
hypothesized, is required and precedes the formation of antibodies against the 
specific determinants it bears, these findings indicate that this first step appears 
to be unrelated to the specificities of the antibodies later produced. These ex- 
periments also illustrate that when a molecule with several antigenic determi- 
nants is presented to the immunological mechanism, the different determinants 
are at some time identified by different immunocompetent cells. 
Although the hapten-PLL albumin complexes can be considered as a special 
and simpler model of hapten-protein conjugates,  the  same relationships  be- 
tween hapten and conveyor molecule for the induction of immunogenicity is 
undoubtedly common to both types of antigen. 
These experiments confirm and extend the findings presented in the com- 
panion paper that each antibody-producing cell synthesizes an antibody of only 
a  single specificity, and probably only a  single homogeneous immunoglobulin 
(14).  This occurs even when the antibody-producing mechanism is presented 
with antigens with several determinants and when the response to these differ- 
ent determinants is linked, as is  the case of DNP-PLL.BSA or DNP-PLL- 
OVA.  All these results contrast sharply with those of Attardi et al. who ob- 
served that as many as 20 % of antibody-producing cells in rabbits immunized 
with two different phages produced antibodies against antigenic determinants 
of both phages (19). If technical error is excluded in their experiments (20, 21, 
22),  the differences observed must depend upon the experim total conditions 
of both studies. The only notable difference between the design of our experi- 
ments and of those of Attardi et al. consists in the time after immunization 
when the antibody-producing cells were examined. In our studies, the experi- 534  CELLULAR  LOCALIZATION  OF  ANTIBODIES 
ments were carried out up to 1 month after immunization, wMle Attardi et al. 
studied the cells of rabbits 6 months to 2 yr after repeated immunization. The 
appearance of cells producing two antibodies with different specificities on the 
basis of prolonged immunization can only be explained by the fact that very 
few cells were initially capable of producing antibodies against  the two speci- 
ficities studied, and that the cells  producing these two immunoglobulins pos- 
sessed a very distinct selective advantage of being able to proliferate over the 
cells producing only antibodies of a single specificity. This selective advantage 
would in time cause them to be present in large numbers. However, in Nossal's 
studies the duration and number of immunizations did not increase the number 
of cells producing antibodies against two separate antigens (23). Although there 
is no known mechanism in the dynamics of antibody synthesis to explain such a 
selective advantage, experiments with hapten-protein conjugates, of the type 
which have been done in these studies, should be repeated to resolve this prob- 
lem very late in the course of immunization, after 6 months or 1 yr. 
One may safely state on the basis of the evidence presented in this and  the 
companion paper (14) that the production of two antibodies by a single plasma 
cell up to 1 month after immunization is at best an extremely rare event since 
it was not observed in a single cell out of 1569 cells examined in animals im- 
munized with hapten-protein antigens or hapten-PLL albumin complex. 
SUMMARY 
Genetic nonresponder guinea pigs incapable of an immune response to DNP- 
PLL alone were immunized with DNP-PLL complexed to ovalbumin or bovine 
serum  albumin.  Under  these  circumstances  the  animals  produce both  anti- 
DNP-PLL antibodies and antibodies directed against  the conveyor albumin. 
Thus immune response to DNP-PLL complexed to conveyor albumin molecules 
can serve as a  simple model of hapten-carrier relationships.  To explore these 
relationships the question whether these two types of antibody are synthesized 
by the same or by different plasma cells was investigated by a combination of a 
double  imml nofluorescent  technique  and  radioautographic  localization  of 
radioactive antigen. 
It was shown that the anti-DNP-PLL antibodies and the antibodies against 
the carrier albumin molecule were produced in separate cells. No cell-producing 
antibodies with both specificities were detected out of 526 cells studied. 
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EXPLANATION  OF PLATES 
PLATE 68 
FIG. I. Lymph node smears of  guinea pig 20-14 immunized with DNP-PLL.BSA. 
In FIG. 1 a the smear has been stained only with rhodamine-labeled anti-DNP anti- 
body. The two brightly stained cells in the upper right and lower left corner are anti- 
DNP-producing cells. The brightly stained object near the cell in the lower left corner 
is an artifact. 
In FIG. 1 b the same smear has been subsequently stained with fluorescein-labeled 
anfi-BSA antibody. The newly stained cell  appears  at the lower edge of the photo- 
graph, below and to the right of the cell previously seen in the lower left corner of Fig. 
1 a. This new cell is a green anti-BSA-producing cell. The orange cells did not change 
in color. THE  JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL. 125  PLATE  68 
(Green et al.: Cellular localization  of antibodies) PLATE 69 
FIG.  2. Lymph node  smear  from  guinea  pig  19-53  immunized with  DNP-PLL.BSA" 
The smear has been stained for both anti-DNP- and anti-BSA producing cells; how- 
ever, in this instance the detecting antigen BSA used in the middle layer was tagged 
with 125I. 
In Fig. 2 a  three stained cells are seen, the two in the left portion of the field were 
stained green indicating that  they were producing anti-BSA antibodies.  The single 
cell in the right portion of the field was stained orange indicating the presence of anti- 
DNP antibody. 
In Fig.  2  b  the  same smear was processed  for  radioautography  and stained with 
Giemsa. In the same field as Fig. 2 a  it is seen that the two cells identified as having 
BSA specificity have many grains localized over them indicating the presence of bound 
BSA-I~aI. In contrast the cell on the right side of the field, containing anti-DNP anti- 
bodies, has no grains over it above background. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  125  PLATE 69 
(Green et al.: Cellular localization of antibodies) 